A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors

NCT01358227 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: PR104

Sponsor

Proacta, Incorporated